Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “MRD Positive Leukemia”

60 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 60 results

Testing effectiveness (Phase 2)Looking for participantsNCT05940961
What this trial is testing

Inotuzumab Ozogamicin in the Treatment of MRD+ After HSCT of ALL

Who this might be right for
ALLMRD-positiveHematopoietic Stem Cell Transplantation
Sheng-Li Xue, MD 42
Early research (Phase 1)Ended earlyNCT05001451
What this trial is testing

Study of GDX012 in Patients With MRD Positive AML

Who this might be right for
Acute Myeloid Leukemia
GammaDelta Therapeutics Limited 3
Testing effectiveness (Phase 2)WithdrawnNCT05604755
What this trial is testing

Prophylactic HQP1351 Therapy Post-transplants on Leukemia After Allo-HSCT

Who this might be right for
Prophylactic HQP1351 TherapyThird Generation TKI
xuna
Testing effectiveness (Phase 2)UnknownNCT05821738
What this trial is testing

Avapritinib in CBF-AML With KIT Mutations

Who this might be right for
Core Binding Factor Acute Myeloid LeukemiaKIT Mutation-Related Tumors
The First Affiliated Hospital of Soochow University 50
Not applicableStudy completedNCT02010931
What this trial is testing

Retrospective Analysis of Survival in Adult MRD Positive Acute Lymphoblastic Leukemia Patients

Who this might be right for
Acute Lymphoblastic Leukemia
Amgen 310
Testing effectiveness (Phase 2)Ended earlyNCT03523429
What this trial is testing

PETHEMA-BLIN-01/PET069014 (BLIN-01)

Who this might be right for
Philadelphia Chromosome-negative or BCR-ABL-negative, CD19-positive ALL
PETHEMA Foundation 11
Not applicableLooking for participantsNCT07131059
What this trial is testing

MRD-positive AML Clinical Study

Who this might be right for
AML, Adult
Institute of Hematology & Blood Diseases Hospital, China 537
Testing effectiveness (Phase 2)Ended earlyNCT04216563
What this trial is testing

ABL001 for the Treatment of Chronic Myeloid Leukemia in Patients Who Are on Therapy With Tyrosine Kinase Inhibitor

Who this might be right for
Philadelphia Chromosome Negative, BCR-ABL1 Positive Chronic Myelogenous Leukemia
M.D. Anderson Cancer Center 7
Not applicableStudy completedNCT03751072
What this trial is testing

Efficacy and Toxicity of Blinatumomab in the French ATU for Adult BCP-ALL R/R, or With MRD+ (FRENCH-CYTO)

Who this might be right for
Acute Lymphoblastic Leukemia, in RelapseAcute Lymphoblastic Leukemia With Failed Remission
Group for Research in Adult Acute Lymphoblastic Leukemia 92
Large-scale testing (Phase 3)Looking for participantsNCT07441291
What this trial is testing

CD19 CAR-T vs DLI for Post-HSCT MRD in Ph- ALL: A RCT

Who this might be right for
B ALLAllogenetic Hematopoietic Stem Cell TransplantationMRD-positive
Peking University People's Hospital 70
Testing effectiveness (Phase 2)Active Not RecruitingNCT07134088
What this trial is testing

Subcutaneous Blinatumomab in Children With R/R and and MRD+ B-Cell Precursor Acute Lymphoblastic Leukemia

Who this might be right for
Relapsed/Refractory B-Cell Precursor Acute Lymphoblastic LeukemiaMinimal Residual Disease + B-Cell Acute Lymphoblastic Leukemia
Amgen 104
Very early researchLooking for participantsNCT07126782
What this trial is testing

The Efficacy and Safety Assessment of Allogeneic γδ T Cells in Patients With MRD-positive AML After Allo-HSCT

Who this might be right for
AML (Acute Myelogenous Leukemia)AML
Institute of Hematology & Blood Diseases Hospital, China 10
Testing effectiveness (Phase 2)Looking for participantsNCT06144606
What this trial is testing

Study of KTE-X19 in Minimal Residual Disease (MRD) Positive B-Cell Acute Lymphoblastic Leukemia (B-ALL)

Who this might be right for
B-Cell Lymphoblastic LeukemiaAcute Lymphoblastic Leukemia
H. Lee Moffitt Cancer Center and Research Institute 60
Testing effectiveness (Phase 2)Looking for participantsNCT06608732
What this trial is testing

Combination of Inaticabtagene Autoleucel With Autologous Hematopoietic Stem Cell Transplantation for Adolescents or Adults With MRD-Positive B-Cell Acute Lymphoblastic Leukemia in Initial Complete Remission.

Who this might be right for
B-cell Acute Lymphoblastic Leukemia
Institute of Hematology & Blood Diseases Hospital, China 20
Testing effectiveness (Phase 2)Study completedNCT02789254
What this trial is testing

FLYSYN in MRD Positive AML

Who this might be right for
Acute Myeloid Leukemia
Synimmune GmbH 31
Testing effectiveness (Phase 2)Study completedNCT04827745
What this trial is testing

Blinatumomab for Treatment of R/R or MRD-positive CD19-Positive MPAL

Who this might be right for
Mixed Phenotype Acute Leukemia (MPAL)Measurable Residual Disease (MRD)
University of Maryland, Baltimore 2
Large-scale testing (Phase 3)Looking for participantsNCT07463651
What this trial is testing

MRD-guided Maintenance Post-HCT: Gilteritini vs Sorafenib

Who this might be right for
Acute Myeloid Leukemia (AML)FLT3-ITD MutationAllogeneic Hematopoietic Cell Transplantation (HCT)+3 more
The First Affiliated Hospital of Soochow University 594
Testing effectiveness (Phase 2)Ended earlyNCT01158885
What this trial is testing

Clofarabine With Cytarabine for Patients With Minimal Residual Disease Positive Leukemia

Who this might be right for
Minimal Residual DiseaseLeukemia, Lymphoblastic, AcuteLeukemia, Myelogenous, Acute
Therapeutic Advances in Childhood Leukemia Consortium 2
Testing effectiveness (Phase 2)Study completedNCT02722668
What this trial is testing

UCB Transplant for Hematological Diseases Using a Non Myeloablative Prep

Who this might be right for
Acute LeukemiaAcute Myeloid LeukemiaAcute Lymphoblastic Leukemia/Lymphoma+22 more
Masonic Cancer Center, University of Minnesota 15
Early research (Phase 1)Looking for participantsNCT06752785
What this trial is testing

CD19/CD22 CAR-T Cell Therapy in MRD-Positive B-lineage Acute Lymphoblastic Leukemia in Children.

Who this might be right for
Acute Lymphoblastic Leukemia
Guangzhou Women and Children's Medical Center 10
Next Page